etofylline has been researched along with Bradycardia in 1 studies
etofylline: etophyllin appeared once in PubMed: Wien Med Wochenschr. 1986 May 15;136(9):213-8 as a combination drug with theophylline (spelt without e, theophllin)
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahiya, A | 1 |
| Sharma, R | 1 |
| Singh, A | 1 |
| Joshi, P | 1 |
| Wardhan, H | 1 |
1 other study available for etofylline and Bradycardia
| Article | Year |
|---|---|
Role of Etophylline and Theophylline Prolonged Release Tablet in COVID-19 Associated Sinus Node Dysfunction.
Topics: Bradycardia; COVID-19; Humans; Pandemics; SARS-CoV-2; Sick Sinus Syndrome; Tablets; Theophylline | 2022 |